DOI: https://doi.org/10.22141/2224-0713.5.99.2018.142967

Migraine and tension cephalalgia

A.Ya. Sabovchyk, M.M. Oros

Abstract


The review deals with the issues of the diagnosis and treatment of migraine and tension cephalalgia. Treatment of both types of cephalalgia consists of abortive and preventive therapy.

Keywords


migraine; tension cephalalgia (tension headache); lornoxicam

References


Неврология / Марко Мументалер, Хейнрих Маттле; пер. с нем.; под. общ. ред. О.С. Левина. — 3-е изд. — М.: МЕДпресс-информ, 2011. — 920 с.: ил.

Болезни нервной системы: Руководство для врачей: В 2 т. — Т. 2 / Под ред. Н.Н. Яхно, Д.Р. Штульмана. — 3-е изд., перераб. и доп. — М.: Медицина, 2003. — 512 с.

Невропатологія: Підручник / В.М. Шевага, А.В. Паєнок, Б.В. Задорожна. — 2-е вид., перероб. і доп. — К.: Медицина, 2009. — 656 с. + 64 с. вкл.

The International Classification of Headache Disorders, 3rd edition (beta version) // Cephalgia. — 2013 Jul. — 33(9). — 629-808.

Jasvinder Chawia. Migraine Headache // MedScape. — 2017 Jan.

Cutrer F.M., Charles A. The neurogenic basis of migrane // Headache. —2008 Oct. — 48(9). — 1411-4. [Medline].

Derry S., Moore R.A., McQuay H.J. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults // Cochrane Database Syst. Rev. — 2010 Nov 10. CD 008040. [Medline].

Matchar D.B. Acute management of migraine: highlights of the US Headache Consortium // Neurology. — 60(7). — S21-3.

[Guideline] American Academy of Neurology. Practice para-meter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology // Neurology. — 1995 Mar. — 45 (3 Pt 1). — 585-7. [Medline].

Dowson A.J., Mathew N.T., Pascual J. Review of clinical trials using early acute intervention with oral triptans for migraine management // Int. J. Clin. Pract. — 2006 Jun. — 60 (6). — 698-706. [Medline].

Brandes J.L., Saper J.R., Diamond M., Couch J.R., Lewis D.W., Schmitt J. et al. Topiramate for migraine prevention: a randomized controlled trial // JAMA. — 2004 Feb 25. — 291(8). — 965-73. [Medline].

Mathew N.T., Rapoport A., Saper J., Magnus L., Klapper J., Ramadan N. et al. Efficacy of gabapentin in migraine prophylaxis // Headache. — 2001 Feb. — 41(2). — 119-28. [Medline].

Tronvik E., Stovner L.J., Helde G., Sand T., Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial // JAMA. — 2003 Jan 1. — 289(1). — 65-9. [Medline].

Schrader H., Stovner L.J., Helde G., Sand T., Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomized, placebo controlled, crossover study // BMJ. — 2001 Jan 6. — 322(7277). — 19-22. [Medline].

Stovner L.J., Hagen K., Jensen R., Katsarava Z., Lipton R.B. Scher A. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide // Cephalgia. — 2007. — 27. — 193-210.

Vos T., Flaxman A.D., Naghavi M., Lozano R., Michud C., Ezzati M. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 // Lancet. — 2012 Dec 15. — 380(9859). — 2163-96. [Medline].

Moraska A., Chandler C. Changes in Psychological Para-meters in Patients with Tension-type Headache Following Massage Therapy: A Pilot Study // J. Man. Manip. Ther. — 2009. — 17(2). — 86-94. [Medline].

Toro-Velasco C., Arroyo-Morales M., Fernandez-de-Las-Penas C., Cleland J.A., Barrero-Hernandez F.J. Short-term effects of manual therapy on heart rate variability, mood state, and pressure pain sensitivity in patient with chronic tension-type headache: a pilot study // J. Manipulative Physiol. Ther. — 2009 Sep. — 32(7). — 527-35. [Medline].

[Guidline] Ruoff G., Urban G. Treatment of primary headache: episodic tension-type headache // Standards of care for headache diagnosis and treatment. — Chicago (IL): National Headache Foundation, 2004.

Paul L. Durham. Calcitonin Gene-Related Peptide (CGRP) and Migraine // Headache. — 2006 Jun. — 46 (Suppl. 1). — S3-S8.

Natoli J.L., Manack A., Dean B. et al. Global prevalence of chronic migraine: a systematic review // Cephalgia. — 2010. — 30. — 599-609.

Bigal M., Serrano D., Buse D. et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population based study // Headache: The Journal of Head and Face Pain. — 2008. — 48(8). — 1157-68.

Blumenfeld A., Varon S., Wilcox T. et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS) // Cephalalgia. — 2011. — 31(3). — 301-15.

Hsu Y.C., Lin K.C., Taiwan Headache Society TGSOTHS. Medical treatment guidelines for acute migraine attacks // Acta Neurol. Taiwan. — 2017 Jun 15. — 26(2). — 78-96.

Goldstein J., Silberstein S.D. et al. Acetaminofen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial // Headache. — 2005 Sep. — 45(8). — 973-82.

Goldstein J., Silberstein S.D. et al. Acetaminofen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study // Headache. — 2006 Mar. — 46(3). — 444-53.

Lecchi M., D’Alonzo L., Negro A., Martelletti P. Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches // Expert Opin. Drug Metab. Toxicol. — 2014 Oct. — 10(10). — 1381-95.

Joshi S., Rapoport A.M. Diclofenac potassium for oral solution (CAMBIA®) in the acute management of a migraine attack: clinical evidence and practical experience // Ther. Adv. Neurol. Disord. — 2007 Apr. — 10(4). — 217-226.

Jeffrey S. FDA Okays First Drug for Migraine Prevention in Adolescents // Medscape Medical News. — Mar 28 2014.

Bendtsen L., Ashina S., Moore A., Steiner T.J. Muscles and their role in episodic tension-type headache: implications for treatment // Eur. J. Pain. — 2016 Feb. — 20(2). — 166-75.

Derry S., Wiffen P.J., Moore R.A. Aspirin for acute treatment of episodic tension-type headache in adults // Cochrane Database Syst. Rev. — 2017 Jan 13. — 1. — CD011888.

Stephens G., Derry S., Moore R.A. Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults // Cochrane Database Syst. Rev. — 2016 Jun 16. — 6. CD011889.

Russell M.B. Tension-type headache in 40-years-olds: a Danish population-based sample of 4000 // J. Headache pain. — 2005 Dec. — 6(6). — 441-7.

Bolukbasi N., Ersanli S., Basegmez C. et al. Efficacy of quick-release lornoxicam versus placebo for acute pain management after dental implant surgery: a randomised placebo-controlled triple-blind trial // Eur. J. Oral. Implantol. — 2012. — Vol. 5. — P. 165-173.

Інструкція для медичного застосування лікарського засобу Ксефокам Рапід.

Parada L., Marstein J.P., Danilov A. Tolerability of the COX-1/COX-2 inhibitor lornoxicam in the treatment of acute and rheumatic pain // Pain Manag. — 2016 Oct. — 6(5). — 445-54. doi: 10.2217/pmt.16.7.

Balfour J.А., Fitton А., Barradell L.B. Lornoxicam A Review of its Pharmacology and Therapeutic Potential in the Management of Painful and Inflammatory Conditions // Drugs. — 1996 Apr. — 51(4). — 639-657




Copyright (c) 2018 INTERNATIONAL NEUROLOGICAL JOURNAL

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта